These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 9160758)
1. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study. Veratran Study Group Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group. DeQuattro V; Lee D; Messerli F Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443 [TBL] [Abstract][Full Text] [Related]
3. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil]. Widimský J; Dzúrik R Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054 [TBL] [Abstract][Full Text] [Related]
4. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Muijsers RB; Curran MP; Perry CM Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112 [TBL] [Abstract][Full Text] [Related]
5. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group. Scholze J; Zilles P; Compagnone D Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623 [TBL] [Abstract][Full Text] [Related]
6. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Messerli F; Frishman WH; Elliott WJ Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873 [TBL] [Abstract][Full Text] [Related]
7. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group. DeQuattro V; Lee D Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890 [TBL] [Abstract][Full Text] [Related]
8. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group. Holzgreve H; Compagnone D; Zilles P J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination. Oren S; Viskoper JR; Zilles P Int J Cardiol; 1996 Jul; 55(1):97-102. PubMed ID: 8839816 [TBL] [Abstract][Full Text] [Related]
12. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
13. Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial. PROCOPA Study Group J Hypertens; 2002 Apr; 20(4):729-37. PubMed ID: 11910310 [TBL] [Abstract][Full Text] [Related]
14. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study. Ruilope LM; Usan L; Segura J; Bakris GL J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814 [TBL] [Abstract][Full Text] [Related]
15. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
16. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes. Schneider M; Lerch M; Papiri M; Buechel P; Boehlen L; Shaw S; Risen W; Weidmann P J Hypertens; 1996 May; 14(5):669-77. PubMed ID: 8762212 [TBL] [Abstract][Full Text] [Related]
17. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study. de Leeuw PW; Notter T; Zilles P J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. Holzgreve H; Nakov R; Beck K; Janka HU Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists. Karlberg BE; Andrup M; Odén A Blood Press; 2000; 9(2-3):140-5. PubMed ID: 10855738 [TBL] [Abstract][Full Text] [Related]